Could a stroke drug fix chemo brain?
NCT ID NCT07454473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a sublingual tablet (Edaravone and Dexborneol) to treat chemo brain, a common side effect of cancer treatment that causes memory, focus, and thinking problems. About 80 adults who have received chemotherapy and now have cognitive issues will take the tablet. The goal is to see if it improves their thinking and quality of life by reducing brain inflammation and damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMO-BRAIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.